Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China · Delayed Price · Currency is CNY 8.52
-0.04 (-0.47%)
Mar 30, 2026, 3:04 PM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 3.45 billion as of March 30, 2026. Its market cap has increased by 0.70% in one year.
Market Cap
3.45B
Enterprise Value
3.30B
Revenue
251.83M
Ranking
n/a
PE Ratio
116.62
Stock Price
8.52
Market Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 3.45B, a decrease of -76.11%. That is a compound annual growth rate of -24.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 3.45B | -9.46% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qingdao Vland Biotech INC. | 3.78B |
| Baolingbao Biology | 3.75B |
| Zhejiang Shouxiangu Pharmaceutical | 3.74B |
| Boji Medical Technology | 3.71B |
| Shanghai Shen Lian Biomedical | 3.55B |
| Yantai Zhenghai Biotechnology | 3.44B |
| Beijing Kawin Technology Share-Holding | 3.39B |
| Landfar Bio-medicine | 3.32B |